La Dépêche Lannemezan

Le docteur Raouf Ghozzi, président de la Fédération française contre les maladies vectorielles à tiques (FFMVT), dont la maladie de Lyme, a reçu dernièrement un chèque de 4.850 € de Didier Cubertafont, un professionnel de la forêt. Le docteur Ghozzi est chef de service de médecine interne au centre médico-chirurgical des Hôpitaux de Lannemezan. C'est à ce titre qu'il a reçu le don des travailleurs forestiers en présence de M. Van Meer, atteint de la maladie de Lyme, dans le cadre de son travail, et actuellement soigné dans le service lannemezanais. Ce ...

Lire la suite...

Mai 2017- le magazine Sciences et Avenir -

Dans son numéro de Mai 2017, le magazine Sciences et Avenir a publié deux articles, l’un sur papier, le second sur internet, mettant en avant les dérives thérapeutiques possibles et réelles que peuvent rencontrer face à leurs souffrances, les malades en errance diagnostique, dans le cadre de la maladie de Lyme et des maladies vectorielles à tiques. Après la consultation d'experts scientifiques reconnus dans le domaine, l'enquête journalistique conclut à une insuffisance scientifique démontrée de l’appareil à micro-courants Vital Harmony de la société Electrophotonique Ingénierie. Le docteur Ghozzi et le professeur ...

Lire la suite...

Le livre du Pr. Perronne vient de paraitre

Perronne Christian   La Vérité sur la maladie de Lyme   Le professeur Perronne, médecin et chercheur de renom, le premier à avoir sensibilisé les pouvoirs publics, raconte dans ce livre de manière claire et précise tout ce qu’on sait aujourd’hui de cette maladie et comment la guérir. Il répond également aux multiples interrogations de ceux, de plus en plus nombreux, qui sont concernés par cette affection. Ce livre nous aide aussi à mieux comprendre et à savoir soigner cet ensemble de maladies mal connues dues à des infections cachées, comme la maladie de Lyme. La ...

Lire la suite...

1er comité de pilotage du PNDS Lyme du 19 janvier 2017

Le premier comité de pilotage du plan national de lutte contre la maladie de Lyme et les maladies transmissibles par les tiques s’est tenu le 19 janvier 2017 au ministère des Affaires sociales et de la Santé, présidé par le Directeur général de la Santé et en présence des agences sanitaires concernées, de la Haute autorité de santé (HAS), de l’Institut national de la recherche agronomique (INRA), de la FFMVT et des associations. La FFMVT était représentée par : * son Président le Dr Raouf Ghozzi, Chef de service médecine interne, hôpital de ...

Lire la suite...

Maladie de Lyme | Le cri d'alarme de 100 médecins: Il y a urgence

l'OBS - 12 juillet 2016 Transmise par les tiques, la maladie de Lyme provoque d'intenses douleurs pouvant aller jusqu'à la paralysie et la démence. En pleine expansion, elle n'est pourtant pas reconnue en France. Dans "l'Obs", plus de 100 médecins lancent un appel d'urgence au gouvernement. Ils lancent l’alerte. De plus en plus souvent, ces médecins sont confrontés à des malades qui errent des années d’hôpital en hôpital. Paralysés, souffrant de douleurs musculaires et articulaires, on leur a diagnostiqué à tort un Alzheimer, une sclérose en plaques ou une spondylartrite. Ils sont ...

Lire la suite...

↑ Revenir à SITE DES PROFESSIONNELS

BIBLIOGRAPHIE

 Int J Gen Med. 2016 Nov 18;9:427-440. eCollection 2016.

Commercial test kits for detection of Lyme borreliosis: a meta-analysis of test accuracy.

Author information


(version sous-titrée en Anglais, seule disponible, désolé)


 

Références Lyme et infections inapparentes

Articles scientifiques référencés

› Afzelius A. Verhandlungen der Dermatologischen Gesellschaft zu Stockholm. Archiv für Dermatologie und Syphilis. 1910. 101, 405-6.

› Aguero-Rosenfeld ME. Lyme disease: laboratory issues. Infect Dis Clin N Am (2008) 22: 301-13.

› Alban PS, Johnson PW, Nelson DR. Serum-starvation induced changes in protein synthesis and morphology of Borrelia burgdorferi, Microbiology. 2000, 146:119-27.

› Ang CW, Notermans DW, Hommes M, Simoons-Smit AM, Herremans T. Large differences between test strategies for the detection of anti-Borrelia antibodies are revealed by comparing eight ELISAs and five immunoblots. Eur J Clin Microbiol Infect Dis (2011) 30: 1027-32.
http://link.springer.com/article/10.1007%2Fs10096-011-1157-6#/page-1

› Assous MV. Laboratory methods for the diagnosis of clinical forms of Lyme borreliosis (in French). Med Mal Infect (2007) 37: 487-95.
http://ffmvt.org/wp-content/uploads/ArticleAssousMMI2007.pdf

› Auwaerter PG, Bakken JS, Dattwyler RJ, Dumler JS, Halperin JJ, McSweegan E, Nadelman RB, O’Connell S, Shapiro ED, Sood SK, Steere AC, Weinstein A, Wormser GP. Antiscience and ethical concerns associated with advocacy of Lyme disease. Lancet Infect Dis (2011) 11: 713-19.

› Bannwarth A. Chronische lymphozytäre Meningitis, entzündliche Polyneuritis und “Rheumatismus” Ein Beitrag zum Problem “Allergie und Nervensystem” in zwei Teilen. Archiv für Psychiatrie und Nervenkrankheiten. 1941. 113, 284-376.

› Bennet R, Lindgren V, Zweygberg-Wirgart B. Borrelia antibodies in children evaluated for Lyme neuroborreliosis. Infection (2008) 36: 463-6.

› Blanc F, Jaulhac B, Fleury M, de Sèze J, de Martino SJ, Rémy V, Blaison G, Hansmann Y, Christmann D, Tranchant C. Relevance of the antibody index to diagnose Lyme neuroborreliosis among seropositive patients. Neurology (2007) 69: 953-8.

› Borgermans L. professor, Perronne C. professor, Balicer R. professor, Polasek O. professor, Obsomer V. ecological and environmental risk expert, . Lyme disease: time for a new approach? editorial BMJ (British Medical Journal)
http://static.www.bmj.com/content/351/bmj.h6520

› Branda JA, Rosenberg, E.S. Borrelia miyamotoi: A lesson in disease discovery. Ann Intern Med (2013) 159: 61-2.

› Bransfield RC. The psychoimmunology of Lyme/tick-borne diseases and its association with neuropsychiatric symptoms. Open Neurol J. 2012, 6, (Suppl 1-M3) 88-93

› Brorson O, Brorson SH. Transformation of cystic forms of Borrelia burgdorferi to normal, mobile spirochetes, Infection. 1997, 25:240-6.

› Brorson O, Brorson,S.H. In vitro conversion of Borrelia burgdorferi to cystic forms in spinal fluid, and transformation to mobile spirochetes by incubation in BSK-H medium. Infection 1998. 26, 144–150. Doi:10.1007/BF02 771839.

› Brorson O, Brorson SH. A rapid method for generating cystic forms of Borrelia burgdorferi, and their reversal to mobile spirochetes, APMIS. 1998, 106:1131-41

› Brorson O, Brorson SH. An in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to metronidazole. APMIS 1999;107-566-76.

› Brorson O, Brorson SH, Henriksen TH, Skogen PR, Schoyen R., Association between multiple sclerosis and cystic structures in cerebrospinal fluid. Infection. 2001, 29: 315-319.

› Brorson O, Brorson SH. Susceptibility of motile and cystic forms of Borrelia burgdorferi to ranitidine bismuth citrate. Int Microbiol. 2001. 4:209-15.

› Brorson O, Brorson SH. An in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to hydroxychloroquine. Int Microbiol 2002;5-25-31.

› Brorson O, Brorson SH. Grapefruit seed extract is a powerful in vitro agent against motile and cystic forms of Borrelia burgdorferi sensu lato. Infection 2007;35-206-8.

› Brorson O, Brorson SH, Scythes J, Mac Allister J, Wier A, Margulis L. Destruction of spirochete Borrelia burgdorferi round-body propagules (RBs) by the antibiotic tigecycline. Proc Natl Acad Sci USA. 2009;106:18656-61.

› Brunner M. Report refuting value of immune complexes to diagnose Lyme disease is invalid. Clin Vaccine Immunol (2006) 13: 304-6.

› Buchwald A. Ein Fall von diffuser idiopathischer Haut-Atrophie. Archiv für Dermatologie und Syphilis. 1883. 10, 553-6.

› Burckhardt JL. Zur Frage der Follikel und Keimzentrenbildung in der Haut. Frankfurter Zeitschrift für Pathologie. 1911. 6, 216, 1317-9.

› Burgdorfer W. On the occult infection in relapsing fevers. Bull Soc Pathol Exot. Filiales. 1954, 47, 664-7

› Burgdorfer W, Barbour AG, Hayes SF, Benach JL, Grunwaldt E, Davis JP. Lyme disease – a tick-borne spirochetosis? Science. 1982. 216, 1317-9.

› Burgdorfer W. Lyme discoverer Willy Burgdorfer breaks silence on heated controversy
http://underourskin.com/news/lyme-discoverer-willy-burgdorfer-breaks-silence-heated-controversy

› Buzzard EF. Spirochetes in M.S. Lancet, 1911: 11:98

› Chmielewska-Badora J, Cisak E, Wojcik-Fatla A, Zwolinski J, Buczek A, Dutkiewicz J. Correlation of tests for detection of Borrelia burgdorferi sensu lato infection in patients with diagnosed borreliosis. Ann Agric Environ Med (2006) 13: 307-11.

› Clarissou J, Song A, Bernede C, Guillemot D, Dinh A, Ader F, Perronne C, Salomon J. Efficacy of a long-term antibiotic treatment in patients with a chronic tick associated poly-organic syndrome (TAPOS). Med Mal Infect 2009;39:108-15.

› Clark KL, Leydet B, Hartman S. Lyme borreliosis in human patients in Florida and Georgia, USA. Int J Med Sci (2013) 10: 915-31.

› Coyle, PK. Borrelia burgdorferi antibodies in multiple sclerosis patients, Neurology. 1989, 39: 760.

› Crowle AJ, May MH. Inhibition of tubercle bacilli in cultured human macrophages by chloroquine used alone and in combination with streptomycin, isoniazid, pyrazimamide, and two metabolites of vitamin D. Antimicrob Agents Chemother 1990;34:2217-22.

› Davis GE, Burgdorfer W. On the suceptibility of the guinea pig to the relapsing fever spirochete Borrelia duttonii. Bull Soc Pathol Exot. Filiales. 1954, 47, 498-50

› Delong AK, Blossom B, Maloney EL, Phillips SE. Antibiotic retreatment of Lyme disease in patients with persistent symptoms: a biostatistical review of randomized, placebo-controlled, clinical trials. Contemp Clin Trials. 2012, 33:1132-42.

› Dietrich T, Geissdörfer W, Schlötzer-Schrehardt U, Holbach L, Schoerner C, Seitz B. Borrelia-associated crystalline keratopathy with intracorneal detection of Borrelia garinii by electron microscopy and polymerase chain reaction. Cornea (2008) 27: 498-500.

› Dong Heun Lee, MD; Ole Vielemeyer, MD. Analysis of Overall Level of Evidence Behind Infectious Diseases Society of America Practice Guidelines.

› Donta ST. Tetracycline therapy for chronic Lyme disease. Clin Infect Dis 1997;25:S52-6.

› Donta ST. Macrolide therapy of chronic Lyme disease. Med Sci Monit 2003;9:136-42.

› Donta ST, Noto RB, Vento JA. SPECT brain imaging in chronic Lyme disease. Clin. Nucl Med (2012) 37: 219-22.

› Embers ME, Barthold SW, Borda JT, Bowers L, Doyle L, Hodzic E et al. Persistence of Borrelia burgdorferi in Rhesus macaques following antibiotic treatment of disseminated infection. PLoS ONE 2012;7: e29914. Erratum PLoS ONE 2012;7. doi: 10.1371.
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0029914

› Fallon BA, Keilp JG, Cordera KM, Petkova E, Britton CB, Dwyer E, et al. A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology 2008;70:992-1003.

› Fallon BA, Lipkin RB, Corbera KM, Yu S, Nobler MS, Keilp JG, Petkova E, Lisanby SH, Moeller JR, Slavov I, Van Heertum R, Mensh BD, Sackeim HA. Regional cerebral blood flow and metabolic rate in persistent Lyme encephalopathy. Arch Gen Psychiatry (2009) 66: 554-63.

› Fehr JS, Bloemberg GV, Ritter C, Hombach M, Lüscher TF, Weber R, Keller PM. Septicemia caused by tick-borne bacterial pathogen Candidatus Neoehrlichia mikurensis. Emerg Infect Dis (2010) 16: 1127-9.

› Feller M., Huwiler K, Schoepfer A, Shang A, Furrer H, Egger M. Long-term antibiotic treatment for Crohn’s disease: Systematic review and meta-analysis of placebo-controlled trials. Clin Infect Dis, 2010, 50, 473-80.

› Feng J, Wang T, Shi W, Zhang S, Sullivan D, Auwaerter PG et al. Identification of novel activity against Borrelia burgdorferi persisters using an FDA approved drug library. Emerg Microbes & Infect 2014; doi:10.1038/emi.2014.53.

› Feng J, Auwaerter PG, Zhang Y. Drug combinations against Borrelia burgdorferi persisters in vitro: Eradication achieved by using daptomycin, cefoperazone and doxycycline. PLoS ONE. 2015. 10: e0117207. Doi: 10.1371/journal.pone.0117207.

› Feng J, Shi W, Zhang S, Zhang, Y. Identification of new compounds with high activity against stationary phase Borrelia burgdorferi from the NCI compound collection. Emerging Microbes Infections. 2015, 4, e31. Doi: 10.1038/emi.2015.31. (Anthracyclines, anti-cancer ++++)

› Feng J, Weitner M, Shi W, Zhang S, Sullivan D, Zhang Y. Identification of additional anti-persister activity against Borrelia burgdorferi from an FDA drug library. Antibiotics, 2015, 4, 397-410

› Feng J, Shi W, Zhang S, Zhang Y. Persister mechanisms in Borrelia burgdorferi: implications for improved intervention. Emerging Microbes Infection. 2015. 4, e51. Doi: 10.1038/emi.2015.51.

› Ferguson, J., Cure unwanted? Exploring the chronic Lyme disease controversy and why conflicts of interest in practice guidelines may be guidelines guiding us down the wrong path. Am J Law Med. 2012, 38, 196-224
https://business.highbeam.com/42/article-1G1-283022008/cure-unwanted-exploring-chronic-lyme-disease-controversy

› Garin C, Bujadoux D. Paralysie par les tiques. Journal des maladies régnantes à Lyon. 1922. 77, 765-7.

› Gherardi RK, Coquet M, Chérin P, Authier FJ, Laforêt P, Bélec et al. Macrophagic myofasciitis: an emerging entity. Groupe d’Etudes et Recherche sur les Maladies musculaires acquises et dysimmunitaires (GERMMAD) de l’Association Française contre les Myopathies (AFM). Lancet, 1998, 352, 347-52

› Ghez D, Bernard L, Bayou E, Bani-Sadr F, Vallée C, Perronne C. Bartonella henselae infection mimicking a splenic lymphoma. Scand J Infect Dis, 2001, 33, 935-6.

› Glaser V. Investigator profile. Interview with Willy Burgdorfer, PhD. Vector-borne Zoonotic Dis. 2006. 6, 430-3.

› Gompels LL, Smith A, Charles PJ, Rogers W, Soon-Shiong J, Mitchell et al. Single-blind randomized trial of combination antibiotic therapy in rheumatoid arthritis. J Rheumatol. 2006. 33, 224-7.

› Grankvist A, Andersson PO, Mattsson M, Sender M, Vaht K, Höper L et al. Infections with the tick-borne bacterium “Candidatus Neoerlichia mikurensis” mimic noninfectious conditions in patients with B cell malignancies or auto-immune diseases. Clin Infect Dis 2014;58,1716-22.

› Grann David. Stalking Dr Steere over Lyme disease. The New York Times. 17 June 2001.

› Greenstein RJ. Is Crohn’s disease caused by a mycobacterium? Comparisons with leprosy, tuberculosis and Johne’s disease. Lancet Infect Dis, 2003, 3, 507-14.

› Gui GPH, Thomas PRS, Tizard MLV, Lake J, Sanderson JD, Hermon-Taylor J. Two-year-outcomes analysis of Crohn’s disease treated with rifabutin and macrolide antibiotics. J Antimicrob Chemother, 1997, 39, 393-400

› Hao Q, Hou X, Geng Z, Wan K. Distribution of Borrelia burgdorferi sensu lato in China. J. Clin. Microbiol. (2011) 49: 647-50.

› Harvey WT, Martz D. Motor neuron disease recovery associated with IV ceftriaxone and anti-Babesia therapy. Acta Neurol Scand. 2006. Doi: 10.1111/j.1600-0404.2006.00727

› Herxheimer K, Hartmann K. Über Acrodermatitis chronica atrophicans. Arch Dermatol. 1902. 61, 57-76.

› Hodzic E, Feng S, Holden K, Freet KJ, Barthold SW. Persistence of Borrelia burgdorferi following antibiotic treatment in mice. Antimicrob Agents Chemother (2008) 52: 1728-36.

› Holl-Wieden A, Suerbaum S, Girschick HJ. Seronegative Lyme arthritis. Rheumatol Int (2007) 27: 1091-3.

› Hunfeld KP, Ruzic-Sabljic E, Norris DE, Kraiczy P, Strl F. In vitro susceptibility testing of Borrelia burgdorferi sensu lato isolates cultured from patients with erythema migrans before and after antimicrobial chemotherapy., Antimicrob Agents Chemother 2005;49-1294-301.

› IDSA Guidelines. Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, Krause PJ, Bakken JS, Strle F, Stanek G, Bockenstedt L, Fish D, Dumler JS, Nadelman RB. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis (2006) 43: 1089-134.

› Keller A, Graefen A, Ball M, Matzas M, Boisguerin V, Maixner F, Leidinger P, Backes C, Khairat R, Forster M, Stade B, Franke A, Mayer J, Spangler J, McLaughlin S, Shah M, Lee C, Harkins TT, Sartori A, Moreno-Estrada A et al. New insights into the Tyrolean Iceman’s origin and phenotype as inferred by whole-genome sequencing. Nature Communications (2012) doi: 10.1038/ncomms1701.

› Kennedy AG. Differential diagnosis and the suspension of judgment. J Med Philos (2013) 38: 487-500.

› Klempner MS, Hu LT, Evans J, Schmid CH, Johnson GM, Trevino RP, Norton D, Levy L, Wall D, McCall J, Kosinski M, Weinstein A. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med (2001) 345: 85-92.

› Krupp LB, Hyman LG, Grimson R, Coyle PK, Melville P, Ahnn S, et al. Study and treatment of post-Lyme disease (STOP-LD). A randomized double masked clinical trial. Neurology 2003;60:1923-30.

› Lamb R, Ozsvari B, Lisanti CL, Tanowitz HB, Howell A, Martinez-Outschoorn UE et al. Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: Treating cancer like an infectious disease. Oncotarget. 2015. 10: 4569-84.

› Liu F, Guo X, Wu R, Ou J, Zheng Y, Zhang B et al. Minocycline supplementation for treatment of negative symptoms in early-phase schizophrenia : A double blind ; randomized, controlled trial. Schizophr Res. 2014. Doi: 10.1016/j/schres.2014.01.011

› Lee DJ, Vielmeyer O. Analysis of overall level of evidence behind Infectious Diseases Society of America practice guidelines. Arch Intern Med 2011; 171, 18-22.
http://www.beyondconformity.org.nz/_literature_80494/Practice_guidelines_article

› Lee SH, Vigliotti JS, Vigliotti VS, Jones W, Shearer DM. Detection of Borreliae in archived sera from patients with clinically suspect Lyme disease. Int J Mol Sci (2014) 15: 4284-98.

› Lewis K. Persister cells, dormancy and infectious disease. Nature (2007) 5. doi: 10.1038/nrmicro1557.

› Lipschütz B. Über eine seltene Erythemform (erythema chronicum migrans). Archiv für Dermatologie und Syphilis. 1913. 118, 349-56.

› Lopes de Carvalho I, Fonseca JE, Marques JG, Ullmann A, Hojgaard A, Zeidner N, Nuncio MS. Vasculitis-like syndrome associated with Borrelia lusitaniae infection. Clin Rheumatol (2009) 27: 1587-91.

› Lubke LL, Garon CF. The antimicrobial agent melittin exhibits powerful in vitro inhibitory effects on the Lyme disease spirochete. Clin Infect Dis 1997;25:S48-51.

› MacDonald, AB. Concurrent neocortical borreliosis and Alzheimer’s disease: demonstration of a spirochetal cyst form. Ann NY Acad Sci. 1988. 539:468-70

› MacDonald AB. Spirochetal cyst forms in neurodegenerative disorders,…hiding in plain sight. Med Hypotheses. 2006. 67:819-32.

› Makhani N, Morris SK, Page AV, Brophy J, Lindsay LR, Banwell BL, Richardson SE. A twist on Lyme: the challenge of diagnosing European Lyme neuroborreliosis. J Clin Microbiol (2011) 49: 455-7.

› Mantovani E, Costa IP, Gauditano G, Bonoldi VLN, Higuchi ML, Yoshinari NH. Description of Lyme disease-like syndrome in Brazil. Is it a new tick borne disease or Lyme disease variation? Braz J Med Biol Res (2007) 40: 443-56.

› Marangoni A, Sparacino M, Cavrini F, Storni E, Mondardini V, Sambri V, Cevenini R. Comparative evaluation of three different ELISA methods for the diagnosis of early culture-confirmed Lyme disease in Italy. J Med Microbiol (2005) 54: 361-7.

› Margos G, Piesman J, Lane RS, Ogden NH, Sing A, Straubinger RK, Fingerle V. Borrelia kurtenbachii sp. nov.: A widely distributed member of the Borrelia burgdorferi sensu lato species complex in North America. Int J Systematic Evolutionary Microbiol; doi:10.1099/ijs.054593-0.

› Masters E, Lynxwiler P, Rawlings J. Spirochetemia after continuous high-dose oral amoxicillin therapy. Infect Dis Clin Pract 1994;3:207-8.

› Mavin S, Milner RM, Evans R, Chatterton JMW, Joss AWL, Ho-Yen DO. The use of local isolates in Western blots improves serological diagnosis of Lyme disease in Scotland. J Med Microbiol 2007; 56, 47-51.

› Mavin S, Evans R, Milner RM, Chatterton JMW, Ho-Yen DO. Local Borrelia burgdorferi sensu stricto and Borrelia afzelii strains in a single mixed antigen improves Western blot sensitivity. J. Clin. Pathol. (2009) 62: 552-4.

› Mechelli R, Manzari C, Policano C, Annese A, Picardi E, Umeton R et al. Epstein-Barr virus genetic variants are associated with multiple sclerosis. Neurology. 2015, 31;84:1362-8

› Middelveen MJ, Burke J, Sapi E, Bandoski C, Filusch KR, Wang Y et al. Culture and identification of Borrelia spirochetes in human vaginal and seminal secretions. F1000Research. 2014, 3:309. Doi: 10.12688/f1000research.5778.3.

› Miklossy J. Alzheimer’s disease – a neurospirochetosis. Analysis of the evidence following Koch’s and Hill’s criteria. J Neuroinflammation 2011; 8: 90

› Miklossy J. Chronic or late Lyme neuroborreliosis: Analysis of evidence compared to chronic or late neurosyphilis. Open Neurology J (2012) 6: 146-57.

› Miklossy J. Historic evidence to support a causal relationship between spirochetal infections and Alzheimer’s disease. Front. Aging Neurosci. 2015, 7. Doi: 10.3389/fnagi.2015.00046

› Murgia R, Cinco M. Induction of cystic forms by different stress conditions in Borrelia burgdorferi. APMIS (2004) 112: 57-62.

› Muriel Vayssier-Taussat, Sara Moutailler, Françoise Féménia, Philippe Raymond, Olivier Croce, Bernard La Scola, Pierre Edouard Fournier, and Didier Raoult. Identification of Novel Zoonotic Activity of Bartonella
http://wwwnc.cdc.gov/eid/article/22/3/15-0269_article

› Nields JA, Kveton JF. Tullio phenomenon and seronegative Lyme borreliosis. Lancet (1991) 338: 128-9.

› Noah DL, Ostroff SM, Cropper TL, Thacker SB. US military officer participation in the Centers for Disease Control and Prevention’s Epidemic Intelligence Service (1951-2001). Mil Med. 2003, 168, 368-72.

› O’Dell JR, Elliott JR, Mallek JA, Mikuls TR, Weaver CA, Glickstein S et al. Treatment of early seropositive rheumatoid arthritis. Doxycycline plus methotrexate versus methotrexate alone. Arthritis Rheum. 2006. 54, 621-7.

› O’Dell JR, Blakely KW, Mallek JA, Eckhoff PJ, Leff RD, Wees SJ et al. Treatment of early seropositive rheumatoid arthritis. A two-year, double-blind comparison of minocycline and hydroxychloroquine. Arthritis Rheum. 2001. 44, 2235-41.

› Ogden NH, Margos G, Aanensen DM, Drebot MA, Feil EJ, Hanincova K, Tyler S, Lindsay LR. Investigation of genotypes of Borrelia burgdorferi in Ixodes scapularis ticks collected during surveillance in Canada. Applied Environ Microbiol (2011) 77: 3244-54.

› Ogrendik M. Effects of clarithromycin in patients with active rheumatoid arthritis. Current Medical Research and Opinion. 2007. 23, 515-22. Doi:10.1185/030079906X167642

› Pedersen MG, Mortensen PB, Norgaard-Pedersen B, Postolache TT. Toxoplasma gondii infection and self-directed violence in mothers. Arch Gen Psychiatry 2012;69:1123-30.

› Perronne C. Lyme disease antiscience. Lancet Infect Dis 2012;12:361-2. doi: 10.1016/S1473-3099(12)70053-1.
http://ffmvt.org/wp-content/uploads/PerronneLancetID2012.pdf

› Perronne C. Lyme and associated tick-borne diseases: global challenges in the context of a public health threat. Front Cell Infect Microbiol 2014;doi:10.3389/fcimb.2014.00074.
http://ffmvt.org/wp-content/uploads/PerronneRevueLymeFrontiers2014-TraductionFrancaise.pdf

› Perronne C. Critical review of studies trying to evaluate the treatment of chronic Lyme disease. Presse Med 2015;doi: 10.1016/j.lpm.2015.06.00
http://ffmvt.org/wp-content/uploads/LymeTreatmentPerronnePresseMed2015.pdf

› Phillips SE, Mattman LH, Hulinska D, Moayad H. A proposal for the reliable culture of Borrelia burgdorferi from patients with chronic Lyme disease, even from those previously aggressively treated. Infection 1998;26-364-7.

› Pick PJ. Über eine neue Krankheit « Erythromelie ». verhandlungen der Gesellschaft deutscher Naturforscher. 1894. 66, 336.

› Pierer M., Rothe K, Quandt D, Schulz A, Rossol M, Scholz R et al. Association of anticytomegalovirus seropositivity with more severe joint destruction and more frequent joint surgery in rheumatoid arthritis. Arthritis Rheum 2012; 64: 1740-9.

› Preac-Mursic, V, Pfister HW, Spiegel H, Burk R, Wilske B, Reinhardt S et al. Formation and cultivation of Borrelia burgdorferi spheroplast-L-form variants. Infection. 1996, 24:218-26.

› Raoult D. Lack of knowledge can anger patients with chronic diseases. Lancet Infect Dis, 2012, 12, 654-5.

› Rolain JM, Colson P, Raoult D. Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century. Int J Antimicrob Agents 2007;30:297-308.

› Rudenko N, Golovchenko M, Ruzek D, Piskunova N, Mallatova N, Grubhoffer L. Molecular detection of Borrelia bissettii DNA in serum samples from patients in the Czech Republic with suspected borreliosis. FEMS Microbiol Letter (2009) 292: 274-81.

› Rudenko N, Golovchenko M, Grubhoffer L, Oliver JH Jr. Updates on Borrelia burgdorferi sensu lato complex with respect to public health. Ticks Tick Borne Dis. (2011) 2: 123-8.

› Rizzoli A, Hauffe HC, Carpi G, Vourc’h GI, Neteler M, Rosà R. Lyme borreliosis in Europe. Eurosurveillance (2011) 16: 1-8.

› Roche-Lanquetot MO, Ader F, Durand MC, Carlier R, Defferière H, Dinh A, Herrmann JL, Guillemot D, Perronne C, Salomon J. Results of a prospective standardized study of 30 patients with chronic neurological and cognitive disorders after tick bites (in French). Med Mal Infect 2008;38:543-8. doi: 10.1016/j.medmal.2008.06.007

› Schardt FW. Clinical effects of fluconazole in patients with neuroborreliosis. Eur J Med Res 2004;9:334-6.

› Scher JU, Sczesnak A, Longman RS, Segata N, Ubeda C, Bielski C et al. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. eLife. 2013. 2: e01202. Doi: dx.doi.org/10.7554/eLife.01202.

› Schutzer SE, Coyle PK, Belman AL, Golightly MG, Drulle J. Sequestration of antibody to Borrelia burgdorferi in immune complexes in seronegative Lyme disease. Lancet (1990) 335: 312-5.

› Schwan TG, Anderson JM, Lopez JE, Fischer RJ, Raffel SJ, McCoy BN, Safronetz D, Sogoba N, Maïga O, Traoré SF. Endemic foci of the tick-borne relapsing fever spirochete Borrelia crocidurae in Mali, West Africa, and the potential for human infection. PLoS Negl Trop Dis (2012) 6: e1924. doi: 10.1371.

› Scrimenti RJ. Erythema chronicum migrans. Arch dermatol. 1970. 102, 104-5.

› Sharma B, Brown AV, Matluck NE, Hu LT, Lewis K. Borrelia burgdorferi, the causative agent of Lyme disease, forms drug-tolerant persister cells. Antimicrob Agents Chemother. 2015. 59, 4616-24. Doi: 10.1128/AAC.00864-15. .. (Mitomycine C)

› Stanek G, Reiter M. The expanding Lyme Borrelia complex – clinical significance of genomic species? Clin Microbiol Infect (2011) 17: 487-93.

› Steere AC, Malawista SE, Hardin JA, Ruddy S, Askenase PW, Andiman WA. Erythema chronicum migrans and Lyme arthritis: The enlarging clinical spectrum. Ann Intern Med. 1977. 86, 685-98.

› Steere AC, Malawista SE, Snydman DR, Shope RE, Andiman WA, Ross MR, Steele FM. Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum. 1977. 20, 7-17.

› Steere AC, Grodzicki RL, Kornblatt AN, Craft JE, Barbour AG, Burgdorfer W, Schmid GP, Johnson E, Malawista SE. The spirochetal etiology of Lyme disease. N Engl J Med. 1983. 308, 733-40.

› Straubinger RK. PCR-based quantification of Borrelia burgdorferi organisms in canine tissues over a 500-day postinfection period. J Clin Microbiol (2000) 38: 2191-9.

› Straubinger RK, Summers BA, Chang YF, Appel MJ. Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment. J Clin Microbiol (1997) 35: 111-6.

› Stricker RB, Moore DH, Winger EE. Clinical and immunologic evidence for transmission of Lyme disease through intimate human contact. J Investig Med. 2004; 52: S151.

› Stricker RB. Counterpoint: long term antibiotic therapy improves persistent symptoms associated with Lyme disease. Clin Infect Dis 2007;45:149-57.

› Stricker RB, Middleveen MJ. Sexual transmission of Lyme disease: Challenging the tickborne disease paradigm. Expert Rev Anti Infect Ther. 2014, 1-4. Doi: 10.1586/14787210.2015.1081056.

› Stricker RB, Johnson L. Lyme disease: call for a “Manhattan Project” to combat the epidemic. PLoS Pathogens (2014) 10: e1003796.

› Strle F, Stanek G. Clinical manifestations of Lyme borreliosis. Curr Probl Dermatol (2009) 37: 51-110.

› Tager FA, Fallon BA, Keilp J, Rissenberg M, Ray Jones C, Liebowitz MR. A controlled study of cognitive deficits in children with chronic Lyme disease. J Neuropsych Clin Neurosciences (2001) 13: 500-7.

› Tan AH, Mahadeva S, Marras C, Thalha AM, Kiew CK, Yeat CM et al. Helicobacter pylori infection is associated with worse severity of Parkinson’s disease. Parkinsonism Relat Disord. 2014 Dec 18. pii: S1353-8020(14)00483-0.

› Tveitnes D, Oymar K, Natas O. Laboratory data in children with Lyme neuroborreliosis, relation to clinical presentation and duration of symptoms. Scand J Infect Dis (2009) 41: 355-62.

› Varela AS, Luttrell MP, Howerth EW, Moore VA, Davidson WR, Stallknecht DE, Little SE. First culture isolation of Borrelia lonestari, putative agent of Southern tick-associated rash illness. J Clin Microbiol (2004) 42:1163-9.

› Vayssier-Taussat M, Moutailler S, Michelet L, Devillers E, Bonnet S, Cheval J, Hébert C, Eloit M. Next generation sequencing uncovers unexpected bacterial pathogens in ticks in Western Europe. PLOS One (2013) 8: e81439.

› Vayssier-Taussat et al. Bartonella. Emerg Infect Dis. 2015. Accepté pour publication novembre 2015.

› Wallet F, Labalette P, Herwegh S, Loïez C, Margaron F, Courcol RJ. Molecular diagnosis of a bilateral panuveitis due to Borrelia burgdorferi sensu lato by cerebral spinal fluid analysis. J Infect Dis (2008) 61: 214-5.

› Wojciechowska-Koszko I, Maczynska I, Szych Z, Giedrys-Kalemba S. Serodiagnosis of borreliosis: indirect immunofluorescence assay, enzyme-linked immunosorbent assay and immunoblotting. Arch Immunol Ther Exp (2011) 59: 69-77.

› Wormser GP. Early Lyme disease. N Engl J Med (2006) 354: 2794-801.

› Wormser GP, Weizner E, McKenna, Nadelman RB, Scavarda C, Molla I et al. Long-term assessment of health-related quality of life in patients with culture-confirmed early Lyme-disease. Clin Infect Dis. 2015. 61, 244-7.

› Yrjänäinen H, Hytönen J, Hartiala P, Oksi J, Viljanen MK. Persistence of borrelial DNA in the joints of Borrelia burgdorferi– infected mice after ceftriaxone treatment. APMIS (2010) 118: 665-73.

› Zhang Y, Träskman-Bendz L, Janelidze S, Langeberg P, Saleh A, Constantine N, et al. Toxoplasma gondii immunoglobulin G antibodies and nonfatal suicidal self-directed violence. J Clin Psychiatry 2012;73:1069-76.

› Zhang Y. Persisters, persistent infections and the Yin–Yang model. Emerging Microbes Infections (2014) 3, e3; doi:10.1038/emi.2014.3.

› Ziska MH, Donta ST, Demarest FC. Physician preferences in the diagnosis and treatment of Lyme disease in the United States. Infection. 1996, 24:182-6.

Journaux généraux

› Baumber Noel. Will G8 funding for dementia research recognise the involvement of stealth pathogens in the global pandemic? The Pharmaceutical Journal. 15 Sept. 2014.

Livres

› Albertat Judith. Maladie de Lyme. Mon parcours pour retrouver la santé. 2012. Thierry Souccar Editions, Vergèze.

› Benarrosh Sophie. A la recherche de ma santé perdue. 2015. Editions du Moment, Paris.

› Berche Patrick. Une histoire des microbes. 2007. John Libbey Eurotext, Paris.

› Carroll Michael Christopher. Lab 257. Caution. The disturbing story of the government’s secret germ laboratory. 2004. HarperCollins Publishers, New York.

› Foucaut Mathieu. Maladie de lyme. L’épidémie silencieuse. Un combat pour nos vies. 2015. Josette Lyon, Paris.

› Freney Jean & Renaud François. La guerre des microbes de l’Antiquité au 11 septembre 2001. 2009. Editions Eska, Paris.

› Horowitz Richard.
Version originale. Solving the mystery of Lyme & chronic disease. 2013. St Martin’s Press, Editor, New York.
Edition française. Soigner Lyme & les maladies chroniques inexpliquées. 2014. Thierry Souccar Editions, Vergèze.

› Jadin Cécile. Une maladie appelée fatigue. 2002. Artcadia Editions.

› Kupiec Jean-Jacques & Sonigo Pierre. Ni Dieu ni gène. Pour une autre théorie de l’hérédité. 2000. Editions du Seuil, Paris.

› Kraaaijeveld Huib. Shifting the Lyme paradigm. 2014. Stili Novi Publishing. Accessible en ligne
http://huib.me/en/work/shifting-the-lyme-paradigm

› Leibowich Jacques. Pour en finir avec le SIDA. 2011. Plon Editeur, Paris.s

› Le Saux Elisabeth. Face à Lyme. Journal d’un naufrage. 2015. Michalon éd. Paris

› Margulis Lynn, Sagan Dorion.

› L’univers bactériel. Les nouveaux rapports de l’homme et de la nature. 1989. Editions Albin Michel, Paris.
Edition américaine originale : Microcosmos. Four billion years of evolution from our microbial ancestors. 1986. Simon & Schuster, Inc., New York.

› Nicolle Charles. Destin des maladies infectieuses. 1933 (in French). Reedited by the Association des Anciens Elèves de l’Institut Pasteur. France Lafayette Ed. Paris (1993). 216 p.

› Payer Lynn. Medicine and culture. 1988, 1996. Henry Holt & Co Inc., New York.

Sites internet

› Prof. Willy Burgdorfer Talks About Lyme Disease and Scientific & Medical Corruption
https://www.youtube.com/watch?v=dCnrUmAPcOE

› European Concerted Action on Lyme Borreliosis EUCALB, Diagnosis: Serology: Minimum standards. www.eucalb.com (accessed 24 March 2014)

› Centers for Disease Control and Prevention. CDC. National notifiable diseases surveillance system. Lyme disease – Borrelia burgdorferi – 2011 Case definition. wwwn.cdc.gov/NNDSS/script/casedef.aspx (accessed 24 March 2014).

› Centers for Disease Control and Prevention. CDC Media Relations. CDC provides estimate of Americans diagnosed with Lyme disease each year. 19 August 2013. www.cdc.gov/media/releases/2013/p0819-lyme-disease.html (accessed 24 March 2014)

http://www.guideline.gov/content.aspx?id=49320

› Prof. Willy Burgdorfer Talks About Lyme Disease and Scientific & Medical Corruption

 


faqs_ffmvt_blanc_171x48

Lien Permanent pour cet article : http://ffmvt.org/site-des-professionnels/bibliographie/